SCHEMBL4092191

SCHEMBL4092191

CCc1cc(-c2ccc(-c3cc(CCC(=O)NCc4cccnc4)[nH]n3)cc2)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.52
LMNA P02545 1/20 0.48
CYP1A2 P05177 4/20 0.46
CYP3A4 P08684 4/20 0.46
CYP2C19 P33261 3/20 0.46
CYP2C9 P11712 1/20 0.46
DHODH Q02127 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
ALDH1A1 P00352 3/20 0.46
USP2 O75604 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 2/20 0.45
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
RECQL P46063 1/20 0.44
HPGD P15428 2/20 0.44
PTAFR P25105 1/20 0.44
PKM P14618 1/20 0.44
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4095792 0.89 HSD17B1 (0.67) HSD17B1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL4094282 0.81 HSD17B1 (0.77) HSD17B1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL4102391 0.79 NR1H4 (0.60) HSD17B1LMNAL3MBTL1ALDH1A1GAA
SCHEMBL4090683 0.78 PKM (0.51) HSD17B1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL4100708 0.77 HSD17B1 (0.62) HSD17B1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL4099539 0.74 HSD17B1 (0.64) HSD17B1L3MBTL1ALDH1A1USP2NPSR1
SCHEMBL4091874 0.73 HSD17B1 (0.78) HSD17B1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL4092400 0.72 HSD17B1 (0.66) HSD17B1LMNAHSD17B10KDM4EGAA
SCHEMBL4085974 0.71 HSD17B1 (0.52) HSD17B1CYP1A2CYP3A4CYP2C19L3MBTL1
SCHEMBL4092430 0.71 NR1H4 (0.61) LMNAL3MBTL1ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186900-A1 COMPOUND STERIX LIMITED (GB) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186900-A1 COMPOUND HSD17B2, HSD17B11, CYP17A1 HSD17B1 4/4885LMNA 1964/4885CYP1A2 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.